Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210028178 210022676 null 17.2 Palliative (P) 2016-01-05 2016-01-11 CNS LGG Irinotecan & Bevacizumab 02 null 210034103 FLAG
210028179 210013910 0 null Disease modification (D) 2017-11-16 2017-11-23 CARBO + ETOPOSIDE + VINCRISTINE N N 210034192 ALEMTUZUMAB + CYCLOPHOSPHAMIDE + METHOTREXATE
210028180 210033721 0 74.4 Palliative (P) 2019-09-08 2019-09-23 STS Rhabdomyosarcoma RMS 2005 IVADo N N 210034315 CLARITY TRIAL
210028181 210013913 1.65 28 Curative (C) 2017-02-10 2017-06-14 Cladribine + Rituximab 2 N 210034377 ALL MAINTENANCE
210028182 210013914 1.82 117.5 Curative (C) 2016-05-18 2016-05-18 NHL 2003 Gp C M1 N N 210034385 DOCETAXEL
210028183 210013916 1.59 68.6 Curative (C) 2018-10-04 2018-11-12 THIOTEPA N N 210034391 CLL210 TRIAL
210028184 210022684 1.62 99.7 Disease modification (D) 2017-02-15 2017-02-15 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE 2 N 210034477 MITOMYCIN
210028185 210013921 1.74 null null 2018-03-26 2018-03-26 CLL210 TRIAL 2 N 210034639 UKALL2003
210028186 210013922 1.43 84 Disease modification (D) 2015-09-12 2015-09-15 Hydroxycarbamide N N 210034650 IRINOTECAN + MDG
210028187 210013923 null 81.8 Palliative (P) 2018-04-25 2018-04-26 FCR IV - Cycle 2 onwards 2 N 210034878 CYCLOPHOSPHAMIDE HIGH DOSE
210028188 210022688 1.69 52.3 Curative (C) 2014-10-06 2014-10-10 IVAC 2 N 210034999 UKALL 60+ TRIAL
210028189 210013926 null 75.6 Palliative (P) 2015-10-19 2015-10-28 BR14 TRIAL null N 210035018 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE
210028190 210013928 1.66 95.6 Palliative (P) 2018-02-04 2018-02-04 DAUNORUBICIN + VINCRISTINE N N 210035172 MELPHALAN
210028191 210028231 null null Disease modification (D) 2018-03-21 2018-03-27 ALL UKALL2003 C: Ph VII Maintenance 2 Y 210035201 AML19 TRIAL
210028192 210013935 null 82.2 null 2016-04-16 2019-03-20 IMMUNOGLOBULIN N N 210035396 DAUNORUBICIN
210028193 210033722 1.86 83.7 Curative (C) 2017-06-21 2017-06-21 CYCLOPHOSPHAMIDE + THALIDOMIDE N null 210035468 CLL210 TRIAL
210028194 210013938 1.68 null Palliative (P) 2015-09-25 2016-10-23 MITOMYCIN 2 N 210035508 ALEMTUZUMAB + CYCLO + FLUDARABINE
210028195 210013939 1.73 null Palliative (P) 2016-08-14 2016-08-22 CARBOPLATIN + Procarbazine N N 210035520 THALIDOMIDE
210028196 210013939 1.82 78.4 Palliative (P) null 2016-06-20 Doxorubicin + Ifosfamide null Y 210035520 CVD
210028197 210013942 1.71 8.8 Not known (9) 2018-01-25 2018-01-26 Cyclophosphamide High Dose null null 210035566 CLARITY TRIAL
210028198 210013944 1.6 89.5 null 2018-07-28 2018-07-29 Fludarabine (po) + Rituximab N N 210035730 MELPHALAN
210028199 210013947 1.64 50 Curative (C) 2016-04-20 2016-04-21 ALL UKALL2003 C: Ph VII Maintenance 02 N 210036052 CLL210 TRIAL
210028200 210013949 1.6 null Curative (C) 2013-11-18 2014-02-11 Docetaxel 75mg/m2 (21 day) N null 210036092 LENALIDOMIDE + RITUXIMAB
210028201 210031599 null 18.1 null 2015-08-18 2015-08-26 Cyclophosphamide High Dose null null 210036240 FLUDARABINE
210028202 210031599 1.77 80 null 2017-11-06 2017-11-09 Bevacizumab+temoz+RT (weeks 1 to 6) 02 N 210036240 CYTARABINE IT + METHOTREXATE
210028203 210013951 1.72 46.3 Curative (C) 2017-08-28 2017-08-28 Cytarabine intrathecal N N 210036418 ALEMTUZUMAB + CYCLOPHOSPHAMIDE + METHOTREXATE
210028204 210022702 1.72 87.6 Disease modification (D) 2017-07-09 2017-07-16 CLL210 TRIAL 1 N 210036454 CYCLO + FLUDARABINE + RITUXIMAB
210028205 210013954 1.59 55.2 Disease modification (D) 2014-08-11 2014-10-04 CLOFARABINE + CYCLOPHOSPHAMIDE + ETOPOSIDE 1 N 210036485 PEMBROLIZUMAB
210028206 210013958 1.64 75.2 Disease modification (D) 2019-09-22 2019-10-03 Ofatumumab Weekly N null 210036496 CLARITY TRIAL
210028207 210031601 1.53 68.6 null 2019-01-31 2019-02-18 Ofatumumab Weekly N N 210036578 ALL
210028208 210022709 1.79 95.5 Curative (C) null 2015-07-23 DABRAFENIB + TRAMETINIB N N 210036643 CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE
210028209 210013967 null 112.8 Curative (C) null 2018-01-26 CARBO + ETOPOSIDE + VINCRISTINE 02 null 210036864 LENALIDOMIDE
210028210 210013968 null 85 Curative (C) 2017-01-25 2017-01-30 ALL UKALL2003 C: Ph VII Maintenance null N 210036881 CYTARABINE HD + METHOTREXATE HD
210028211 210013969 1.55 null null 2018-12-16 2019-01-28 Hydroxycarbamide 02 N 210036916 FLAG
210028212 210013970 1.7 61.6 Disease modification (D) 2014-02-26 2014-04-02 Cytarabine HD + Methotrexate HD 02 N 210036941 ABIRATERONE
210028213 210013972 1.83 null Curative (C) 2016-10-21 2016-10-21 AML 19 TRIAL N N 210037146 OFATUMUMAB
210028214 210013975 1.82 null Disease modification (D) 2013-10-29 2013-10-29 Erlotinib N N 210037309 MACE
210028215 210013976 1.57 28 Palliative (P) 2016-06-12 2016-06-27 Cyclophosphamide High Dose 02 N 210037404 ABIRATERONE
210028216 210028244 1.67 42.2 Curative (C) 2014-10-25 2014-10-29 CARBOPLATIN + VINORELBINE 02 null 210037481 ABVD
210028217 210013978 1.77 null Curative (C) 2018-01-19 2018-11-01 Fludarabine IV N N 210037672 LENALIDOMIDE + RITUXIMAB
210028218 210013980 null 85.6 Palliative (P) 2019-05-03 2019-05-10 FLUDARABINE N null 210037675 CAPECITABINE
210028219 210031605 1.63 82.3 Curative (C) 2018-08-11 2018-08-16 CYTARABINE N null 210037833 IMMUNOGLOBULIN
210028220 210013985 1.59 null Disease modification (D) 2018-03-31 2018-04-27 Packer Maintenance Regimen null N 210037888 CVD
210028221 210013986 1.76 102 Curative (C) 2017-11-25 2017-11-25 CLARITY Trial null N 210038079 UKALL2003
210028222 210013990 null 16.8 Palliative (P) 2016-03-31 2016-11-01 Packer Maintenance Regimen null N 210038210 CLARITY TRIAL
210028223 210013993 1.69 47 Curative (C) 2017-03-05 2017-03-29 Maintenance Therapy ALL N N 210038619 CAV
210028224 210013995 1.64 26.8 Curative (C) 2017-11-01 2018-08-02 Packer Maintenance Regimen 2 N 210038641 UKALL2003
210028225 210013995 1.62 68.6 null 2017-09-17 2017-10-14 Docetaxel 100mg/m2 (21 day) N Y 210038641 CODOX M
210028226 210013999 null 49.7 Disease modification (D) 2017-03-04 2017-06-02 AML 19 TRIAL null N 210038854 CYCLO + FLUDARABINE + RITUXIMAB
210028227 210014001 null 48.1 Palliative (P) 2017-12-16 2017-12-16 CYTARABINE N N 210038863 FLUOROURACIL